Economists agree that sustainable economic growth depends on higher-value, knowledge-based services, high-tech manufacturing, research and development, and less reliance on the export of commodities and natural resources. Domestic manufacturing sectors within ASEAN member states, while increasingly diversified, are largely focused on the assembly of products designed and manufactured elsewhere. There is also too much reliance on the export of natural resources. For ASEAN countries to join the ranks of high-income countries, they need to continue to commit and invest in the building of a knowledge economy.
Trade and Intellectual Property
Improving access to quality healthcare remains a key area of action for the member states of the United Nations. As they gather in New York for the 74th UN General Assembly, focus is upon the health-related Sustainable Development Goals. This paper adds to this debate by providing international trade policy suggests that would enhance universal healthcare by reducing unnecessary medicine costs and accelerating access to medicine.
This study develops a quantitative analysis of the impact of the Canada-United States-Mexico Agreement (CUSMA), as signed on 30 November 2018. The CUSMA represents a major overhaul of the now-dated 1994 North American Free Trade Agreement (NAFTA) and is based largely on the Trans-Pacific Partnership (TPP) text, signed in 2016, from which the Trump administration withdrew in January 2017.
The Philippine Institute for Development Studies (PIDS) has released its annual report for 2018 detailing its accomplishments in research, policy recommendation, and collaboration in the following fields: Agriculture, natural resources, and environmental management; human development, labor markets, and poverty; institutions, law, and economics; macroeconomics, finance, and growth; public economics and governance; regional, urban, and rural development; science, technology, and innovation; and trade and industry and international economy.
As parties to the United States-Mexico-Canada Agreement (USMCA), Canada and Mexico have agreed to adopt important intellectual property protections for biologic medicines. Most significantly, both countries have agreed to increase the term of regulatory data protection (RDP) for new biologic medicines to ten years, thereby approaching the 12 years provided by the United States. Currently, Canada provides an eight-year term, while Mexico offers no protection.
In a world where economic growth increasingly depends on “intangible” products and services based on human know-how, knowledge and creativity, only those countries that have the right policy attitude to innovation will thrive.
Robust intellectual property (IP) protection is vital for biopharmaceutical innovation. It provides the incentives and business certainty needed to attract and sustain long-term investment in prevention, treatments and cures. IP rights have little value without enforcement, however.
Canadian courts, in particular the Supreme Court of Canada, have in recent years issued intellectual property (IP) judgments that were problematic, even erroneous, Munk Senior Fellow Richard Owens said today.
The knowledge economy is the future. Knowledge intensive sectors are expanding their reach throughout the economy and have huge potential to increase productivity and job creation. A solid legal framework of intellectual property rights is vital to ensure investment into these knowledge intensive sectors.